AstraZeneca PLC’s Delaware Site To Get $100 Million Facelift

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

AstraZeneca announced plans this morning for a $100 million investment over the next five years at its supply site off Old Baltimore Pike in Bear. The supply facility is a key strategic site in the firm’s global supply chain and handles the vast majority of packing for the North American market, according to Alisha Martin, AstraZeneca spokesperson. It is one of three U.S. distribution sites and one of 25 production facilities across 17 countries for the biopharmaceutical firm.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC